Bitter pill for pharmacists

Many French pharmacists are falling on hard times after a year of falling revenues. Those most affected are in rural or semi-rural areas, where there is a growing shortage of doctors willing to set up practice or where resident GPs are leaving for the more populous towns.

EH correspondent Keith Halson
EH correspondent Keith Halson

In one central region of the country, pharmacists reported a drop in sales of almost 7% in 2006. Delegates at a recent regional conference complained: ‘What is the point of having a pharmacy in a village where there is no doctor? Local people have to travel to the nearest town to seek medical attention, so naturally they also buy their medicines there.’

A change in prescribing practice has also hit pharmacists’ profits. They are now required to supply at least 74% of medicines in generic form rather than those made by brand-name drugs companies.

08.03.2007

More on the subject:

Related articles

Photo

News • Study finds faster regain than ending diet programmes

GLP-1 discontinuation: weight-loss drugs work – until you stop

Drawbacks of GLP-1 discontinuation: People tend to regain weight rapidly after stopping weight-loss drugs - and faster than after ending behavioural weight loss programmes - according to new research.

Photo

Article • Hengrui Pharma charts its global strategy at ESMO

Meet the Chinese company advancing European oncology

Hengrui, one of China's leading pharmaceutical companies, is preparing to bring its cancer therapies to international markets. At the ESMO congress in Berlin, Yuting (Shelley) Liu, Head of China…

Photo

News • Weight loss and diabetes medication

GLP-1 agonists may interfere with cancer imaging, new study finds

GLP-1 receptor agonists are widely prescribed for individuals with diabetes and weight loss. However, these medications may adversely affect the interpretation of cancer imaging, new research finds.

Subscribe to Newsletter